Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Dec 13;51(6):2943-2950.
doi: 10.3906/sag-2102-352.

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

Özhan Özgür  1 , Hakkı Timur Sindel  1
Affiliations
Comparative Study

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

Özhan Özgür et al. Turk J Med Sci. .

Abstract

Background/aim: Treatment of hepatic hemangiomas is a controversial topic, and traditional treatment is surgical excision. Transcatheter arterial embolisation (TAE) and transcatheter arterial chemoembolisation (TACE) have been reported as minimally invasive treatment methods. To the best of our knowledge, there are no studies comparing use of TACE and TAE for hepatic hemangioma treatment. The aim of the study is to compare symptom resolution, size reducing effects, and complications of TACE and TAE for the treatment of giant hepatic hemangiomas.

Materials and methods: A total of 104 patients underwent TACE using bleomycin, and 108 patients underwent TAE. The patients were followed-up for 2 year and follow-up images at 6 months, 12 months, and 24 months were acquired. Lesion volumes in both follow-up images were calculated. The patients were examined for any possible procedure related complications as well as the status of their initial symptoms.

Results: The shrinkage period was determined to have ended after 12. month in both groups. The results of the two-way mixed ANOVA showed that there was significant main effect of procedure type (p ≤ 0.001) on hemangioma volumes. Similarly, there was a significant interaction between procedure and time (p ≤ 0.001).

Conclusion: Both methods are effective in symptomatic relief in properly selected patients. However, TACE causes greater volume reduction with less pain and, therefore, is the better endovascular treatment option.

Keywords: Liver; angiography; bleomycin; embolization; hemangioma.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Digital subtraction angiography image showing the sinusoids of giant hemangioma filled with lipiodol-bleomycin mixture.
Figure 2
Figure 2
A: Arterial phase CT image of a hepatic giant hemangioma before TAE treatment arrow shows the lesion. B: Arterial phase CT image of a hepatic giant hemangioma 12 months after TAE treatment arrow shows the lesion.
Figure 3
Figure 3
A: Arterial phase CT image of a hepatic giant hemangioma before TACE treantment. Arrows show the lesions. B: Arterial phase CT image of a hepatic giant hemangioma 12 months after TACE treatment. Arrows show the lesions.
Figure 4
Figure 4
Comparison of postembolization pain symptom of two procedures according to the number of patients according to McCaffery pain scale (TAE n = 108, TACE n = 104 patients).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Giavroglou C, Economou H, Ioannidis I, Hirano A, Kimura T, et al. Arterial embolization of giant hepatic hemangiomas. CardioVascular and Interventional Radiology. 2003;26:92–96. doi: 10.1007/s00270-002-2648-8. - DOI - PubMed
    1. Bozkaya H, Cinar C, Besir FH, Parildar M, Oran I. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin. CardioVascular and Interventional Radiology. 2014;37:101–107. doi: 10.1007/s00270-013-0618-y. - DOI - PubMed
    1. Toro A, Mahfouz AE, Ardiri A, Malaguarnera M, Malaguarnera G, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Annals of Hepatology. 2014;13:327–339. doi: 10.1016/S1665-2681(19)30839-7. - DOI - PubMed
    1. Srivastava DN, Gandhi D, Seith A, Pande GK, Sahni P. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdominal Imaging. 2001;26:510–514. doi: 10.1007/s00261-001-0007-x. - DOI - PubMed
    1. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: Are there any indications for resection? World Journal of Surgery. 1995;19:19–24. doi: 10.1007/BF00316974. - DOI - PubMed

Publication types

MeSH terms

-